Type 2 Diabetes Mellitus: A Pathophysiologic Perspective

被引:24
|
作者
Westman, Eric C. [1 ]
机构
[1] Duke Univ, Dept Med, Durham, NC 27708 USA
来源
FRONTIERS IN NUTRITION | 2021年 / 8卷
关键词
type; 2; diabetes; insulin resistance; pre-diabetes; carbohydrate-restricted diets; hyperinsulinemia; hyperglycemia; LOW-CARBOHYDRATE; KETOGENIC DIET; GLUCOSE; METABOLISM; OBESITY; FAT;
D O I
10.3389/fnut.2021.707371
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Type 2 Diabetes Mellitus (T2DM) is characterized by chronically elevated blood glucose (hyperglycemia) and elevated blood insulin (hyperinsulinemia). When the blood glucose concentration is 100 milligrams/deciliter the bloodstream of an average adult contains about 5-10 grams of glucose. Carbohydrate-restricted diets have been used effectively to treat obesity and T2DM for over 100 years, and their effectiveness may simply be due to lowering the dietary contribution to glucose and insulin levels, which then leads to improvements in hyperglycemia and hyperinsulinemia. Treatments for T2DM that lead to improvements in glycemic control and reductions in blood insulin levels are sensible based on this pathophysiologic perspective. In this article, a pathophysiological argument for using carbohydrate restriction to treat T2DM will be made.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Pathophysiologic heterogeneity in the development of type 2 diabetes mellitus in Korean subjects
    Kang, HW
    Kim, DJ
    Lee, MS
    Kim, KW
    Lee, MK
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 69 (02) : 180 - 187
  • [2] Type 2 diabetes mellitus: a cardiovascular perspective
    Varughese, GI
    Tomson, J
    Lip, GYH
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (07) : 798 - 816
  • [3] Alzheimer's disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links
    Rojas, Milagros
    Chavez-Castillo, Mervin
    Bautista, Jordan
    Ortega, Angel
    Nava, Manuel
    Salazar, Juan
    Diaz-Camargo, Edgar
    Medina, Oscar
    Rojas-Quintero, Joselyn
    Bermudez, Valmore
    [J]. WORLD JOURNAL OF DIABETES, 2021, 12 (06)
  • [4] Type 2 diabetes mellitus in childhood - A global perspective
    Laron, Z
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2002, 15 : 459 - 469
  • [5] A Clinical Perspective of Canagliflozin in the Management of Type 2 Diabetes Mellitus
    Nardolillo, Annemarie
    Kane, Michael P.
    Busch, Robert S.
    Watskyand, Jay
    Hamilton, Robert A.
    [J]. CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2014, 7 : 25 - 30
  • [6] Type 2 diabetes mellitus in children and adolescent: an Indonesian perspective
    Pulungan, Aman Bhakti
    Afifa, Ireska Tsaniya
    Annisa, Diadra
    [J]. ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2018, 23 (03) : 119 - 125
  • [7] Resistant starch and type 2 diabetes mellitus: Clinical perspective
    Kim, Min Kyung
    Park, Juri
    Kim, Doo-Man
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2024, 15 (04) : 395 - 401
  • [8] Guideline: TYPE 2 DIABETES MELLITUS THERAPY: METFORMIN A Critical Perspective
    Pinto, Daniel
    Heleno, Bruno
    Gallego, Rosa
    Santos, Isabel
    Santiago, Luiz Miguel
    Maria, Vasco
    [J]. ACTA MEDICA PORTUGUESA, 2011, 24 (02) : 331 - 338
  • [9] Exploring the Type 2 Diabetes Mellitus Experience from the Patient Perspective
    Yu-Isenberg, Kristina
    Gray, Geof D.
    Foley, Catherine
    Stokes, Jonathan T.
    Shields, Alan
    Dickie, Gavin
    Lamoureux, Roger
    Jackson, Clark V.
    Padilla, Brad
    Polonsky, William
    [J]. DIABETES, 2018, 67
  • [10] Hormone replacement therapy in type 2 diabetes mellitus: a cardiovascular perspective
    Sattar, N
    McKenzie, J
    MacCuish, AC
    Jaap, AJ
    [J]. DIABETIC MEDICINE, 1998, 15 (08) : 631 - 633